Metacognitive Therapy for Comorbid Anxiety Disorders: A Case Study by Sverre U. Johnson & Asle Hoffart
fpsyg-07-01515 September 28, 2016 Time: 15:55 # 1
CASE REPORT
published: 30 September 2016
doi: 10.3389/fpsyg.2016.01515
Edited by:
Nuno Conceicao,
University of Lisbon, Portugal
Reviewed by:
Michelle Dow Keawphalouk,
Harvard University, USA
Michael Noll-Hussong,
University of Ulm, Germany
*Correspondence:
Sverre U. Johnson
sverre.johnson@modum-bad.no
Specialty section:
This article was submitted to
Psychology for Clinical Settings,
a section of the journal
Frontiers in Psychology
Received: 20 July 2016
Accepted: 20 September 2016
Published: 30 September 2016
Citation:
Johnson SU and Hoffart A (2016)
Metacognitive Therapy for Comorbid
Anxiety Disorders: A Case Study.
Front. Psychol. 7:1515.
doi: 10.3389/fpsyg.2016.01515
Metacognitive Therapy for Comorbid
Anxiety Disorders: A Case Study
Sverre U. Johnson1,2* and Asle Hoffart1,2
1 Clinical Psychology, University of Oslo, Oslo, Norway, 2 Modum Bad Psychiatric Center, Vikersund, Norway
We aimed to systematically evaluate a generic model of metacognitive therapy (MCT)
with a highly comorbid anxiety disorder patient, that had been treated with diagnosis-
specific cognitive-behavioral therapy (CBT) without significant effect. Traditionally, CBT
has progressed within a disorder-specific approach, however, it has been suggested
that this could be less optimal with highly comorbid patients. To address comorbidity,
transdiagnostic treatment models have been emerging. This case study used an
AB-design with repeated assessments during each therapy session and a 1-year follow-
up assessment to evaluate the effectiveness of MCT. Following 8 sessions of MCT,
significant decrease in anxiety and depression symptoms, as well as loss of diagnostic
status was observed. Outcomes were preserved at 12 months follow up. The generic
model of MCT seems promising as an approach to highly comorbid mixed anxiety
depression patients. Further testing using more powered methodologies are needed.
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INTRODUCTION
According to Kessler et al. (2012), 50% of people with a mental disorder in a given year, meet criteria
of multiple disorders. Thus, comorbidity is the norm among patients presenting for treatment in
clinical practice. Comorbidity is further associated with higher level of disease burden (Gadermann
et al., 2012), lowers the likelihood of recovery from anxiety disorders and increases the likelihood
of their recurrence (Bruce et al., 2008). The high rates of comorbidity in clinical practice highlights
the possibility that treatments that are not focused on a particular diagnosis, but are applicable to
class of disorders, could be more effective than treatment of a single disorder (Moses and Barlow,
2006). Such treatments, often called transdiagnostic treatments models (Wells, 2009; Barlow et al.,
2011) even if equally effective as more focused treatments (Norton and Barrera, 2012; Titov
et al., 2015), could be less costly, more applicable, and less demanding than diagnosis-specific
treatments.
The metacognitive model (Wells, 2009) has a clear focus on repetitive thinking, which seems
to be general across psychological disorders (Wells, 2009; McEvoy et al., 2010). Moreover,
Metacognitive therapy (MCT) is based on the Self-Regulatory Executive Function Model (S-REF),
which highlights the similarities in maladaptive cognitive processing across different psychological
disorders (Wells and Matthews, 1996; Wells, 2009). Thus, the model is transdiagnostic and can
allow for high levels of comorbidity. A central concept in MCT is the cognitive attentional
syndrome (CAS) consisting of three elements: (a) Perseverative thinking in the form of worry
and rumination, (b) focusing attention on sources of threat- perceptions as thoughts, emotions,
and physical sensations, and (c) coping behaviors that backfire (avoidance, thought suppression,
alcohol, or substance abuse).
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Worry and rumination, two key features of the CAS, are
examples of transdiagnostic processes (Harvey et al., 2004).
Both worry and rumination share core features, as they both
consist of repetitive, negatively valenced thoughts (Watkins,
2008). However, they differ in that rumination is hind-sighted
while worry is future oriented (Papageorgiou and Wells, 1999).
The content of worry can differ between diagnoses, although the
process is the same. For example, individuals with panic disorders
worry about the possibility of having a panic attack, patients with
social anxiety worry about being in the center of attention and
being humiliated, and people with obsessive-compulsive disorder
(OCD) can worry about contamination.
Worry and rumination is maintained by two different sets
of metacognition (Wells, 2009). Positive metacognitive beliefs
consist of using worry and rumination as a way of regulating
their emotions, such as: “If I ruminate about my problems I
will find an answer”. Negative metacognitive beliefs concern the
negative interpretation of internal cognitive events, and belong
to the domain of lack of control and danger, such as: “If I can‘t
stop worrying about this I will go mad”. Negative metacognitions
of control and danger increase anxiety and the feeling of losing
mental control, since they alter the significance of internal
cognitive events like thoughts, feelings and physical sensations.
Metacognitive therapy has been found effective for different
disorders like generalized anxiety disorder (GAD), posttraumatic
stress disorder (PTSD), and major depressive disorder (MDD;
Normann et al., 2014). Further, preliminary results indicate a
transdiagnostic effect of MCT (Nordahl, 2009; McNicol et al.,
2013). McNicol et al. (2013) conducted a case study of a cancer-
survivor with high levels of PTSD symptoms and concluded that
MCT could be effective in the treatment of highly comorbid
patients. Nordahl (2009) assessed the effectiveness of MCT, as
compared to CBT, applied to a sample of treatment resistant
patients in a clinical setting. Patients receiving MCT displayed
significantly greater reductions in anxiety and worry levels than
those receiving CBT. However, Nordahl and McNicol did not
use the generic MCT-model and case formulation described
by Wells (2009), providing the impetus for the current case
study.
In this case study, it is hypothesized that MCT would be
well suited for treating highly comorbid patients due to explicit
focus on transdiagnostic processes. This case study used an AB-
design (Barlow et al., 2009), with a 1-year follow-up assessment
to evaluate the effectiveness of MCT.
BACKGROUND
Case Study: Presenting Problems and
Diagnosis
This case pertains to a 32-year-old woman, referred to as
Susan (a pseudonym), who had a lifelong history of anxiety
and depression, had been in the health system since early
adulthood and was described as a treatment resistant case by the
general practitioner who referred her. Susan gave full informed
consent to the writing of this article. Previously she had received
diagnosis-specific CBT at three separate periods, as specified
by the referrals. One treatment consisted of approximately
14 months of therapy and another lasted 10 months. Both
treatments were focused on specific anxiety disorders such
as social phobia and panic disorder, and consisted of weekly
sessions. Susan had also attended CBT group therapy for anxiety
disorder without significant effect. Moreover, she had also used
medication (SSRI and Benzodiazepines) at two different time
periods. However, she did not use medications when starting
MCT-treatment, or over the course for therapy. Further, Susan
did not have any drug abuse history or somatic comorbidities.
When entering treatment, Susan was on sick leave. She had
support from her husband and had responsibility for the children
despites her troubles. The treatment for Susan was paid by the
Norwegian national health service.
Susan reported multiple ongoing concerns related to attending
work and social meetings. Susan was anxious that people could
see that she was nervous, and she worried about other people
thoughts about her. As a consequence meetings and work
were avoided, and she was not able to stay in work due to
the social anxiety. Susan reported tiredness and exhaustion
persistently. Thoughts like “why have I not gotten better from
therapy?” and “what if I can’t take care of my kids?” were
prevalent, which again led to demoralization. Further, Susan
described a chronic feeling of low mood, as well as other
symptoms of depression, like fatigue and sleep-onset difficulties.
The symptoms had been present for several years and interfered
significantly with her daily life. Moreover, the patient reported
excessive and uncontrollable worries concerning different issues
like finances and physical health. These worries and associated
physiological symptoms (e.g., restlessness, fatigue), led to distress
and interfered with her daily life because she felt that she was
not able to focus on the task at hand. The most prominent
fear was for example that something negative could happen to
her children, and that she would be responsible for harming
them. She was also frightened that she had forgotten to turn off
electrical equipment’s in the house and that the house could burn
down, which led to extensive compulsive checking more then a
hour a day.
ASSESSMENT
The diagnostic evaluation was undertaken by using the Mini-
International Neuropsychiatric Interview (MINI; Sheehan et al.,
1998) at start of treatment and at 1-year follow-up. The
Symptom Checklist-90 (SCL-90; Derogatis, 1977) was used at
evaluation, 2 months before treatment, start of treatment, after
treatment, and at 1-year follow-up. The CAS-1, which assesses
all the components in CAS (Wells, 2009) and Beck Depression
Inventory II (Beck et al., 1995), were completed at every
session throughout the treatment, after treatment and at 1-year
follow-up.
DISCUSSION
Treatment
Susan met diagnostic criteria for F40.1 social anxiety disorder
(SAD), F41.1 GAD, F33.1 MDD, F42.2 OCD, and F40.2 specific
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phobia at the start of treatment. The patient received 8 individual
50 min therapy sessions of MCT using the generic model (Wells,
2009) in an in-patient setting over 8 weeks. Outside the individual
therapy, the patient participated in the common activity in the
ward, consisting of meetings and one physical exercise session
per week. Her individual therapist (first author of this paper)
had 2 years of formal clinical training in MCT and received
supervision from the second author on a weekly basis who
is an expert in the treatment of anxiety disorders. A generic
metacognitive model consists of several phases as described in the
next paragraphs:
1. Generating case conceptualization
2. Introducing detached mindfulness (DM)
3. Working on negative metacognitive beliefs concerning
danger and lack of control
4. Working on positive metacognitive beliefs
5. Removing threat monitoring and maladaptive coping
behaviors
6. Reinforcing new plans for processing
7. Relapse prevention
Case Formulation and Psychoeducation
Susan‘s thinking style consisted of different forms of worry and
rumination, the content of which varied according to different
fears. She focused her attention inward, looking for sign of
illness, but also monitored the faces of other people to see
if they liked her or not. She also used a range of strategies,
such as avoidance of people, seeking reassurance, thought
control, and physical activity to avoid or remove thoughts
that could trigger worry and rumination. The formulation
suggested that Susan‘s main strategies to regulate emotions were
(a) extended thinking (b) threat monitoring, and (c) seeking
reassurance, maintained by negative metacognitions about the
uncontrollability and danger of thinking. During the stage of case
formulation the difference between triggers and response were
emphasized.
Negative Metacognitions and Detached
Mindfulness
The patient was introduced to the contrast between
disengagement and thought suppression by an experiment:
first trying not to think about “what if I don’t get better”, a
typical trigger for the patient, followed by free association task
(Wells, 2005). The task consisted of saying aloud a series of
neutral words and the patients was instructed to just observe
her mental experience in a detached manner, which gave her an
early contrast between the old way of handling triggers (thought
control) and the new way called DM. Homework for Susan was
to acknowledge triggers, apply DM, and postpone trigger-related
worry to a 15-minute period in the afternoon.
Low meta-awareness is a common challenge in highly
comorbid patients. Therefore when the therapist saw signs that
Susan started a process of worry and rumination in the session, he
would raise his arm, and Susan would point out the worry process
by saying loudly “Here comes the worry” and postpone it, which
led to a playful atmosphere. Later in therapy remaining negative
metacognitions were challenged by having Susan deliberately try
to worry as much as possible in the session and then stop, as
a way of testing the patient belief that worry is uncontrollable.
Positive metacognitions were targeted with statements like “I
understand that you think you need some form of worry, but how
do you know that you are worrying for the right things”. This
FIGURE 1 | Scores on the CAS1 (left y-axis) and scores on the BDI (right y-axis) across pretreatment, metacognitive therapy (MCT), and 1-year
follow-up. BDI, Beck Depression Inventory; CAS1, Cognitive Attentional Syndrome Scale-I.
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metacognitive focused socratic dialog weakened Susan beliefs
that worry was helpful.
Threat Monitoring, Old and New Plan,
and Generalization
Threat monitoring was addressed with specific techniques such
as attention training (Wells, 2009), and concrete exercises, like
having the patients focusing attention toward threats compared
to focusing on neutral stimuli like eye color. Again this helped
the patient to switch from old to new strategies. In the end of
therapy, the patient was helped to summarize how she previously
responded to various triggers (old plan), and how she would do it
in the future (new plan). This work promoted generalization, as
Susan realized that worry and rumination was a common theme
across her problems.
Results
Figure 1 shows Susan‘s BDI and CAS-1 scores during
pretreatment, start of treatment, end of treatment and 1-year
follow-up. Inspection of graphed data in Figure 1 indicates
substantial reductions on the CAS-1 and BDI during the
treatment phase. Both the CAS-1 and BDI were in the normal
range at the end of treatment. Her scores on the CAS-
1 demonstrated that symptom reduction was associated with
changes in metacognitive beliefs. Readministration of the MINI
at 1-year follow-up revealed that Susan no longer met diagnostic
criteria for any of the prior ICD-10 diagnosis. The reliable change
index (RCI) was calculated to determine the clinical significance
of change in SCL 90 and the BDI. A RCI critical score is
formulated based on the patient’s pre- and post-treatment scores
and standard deviation, pre- and post-test scores and test–retest
reliability scores from a treatment sample. To determine whether
the patient experienced clinically significant change in general,
norms from Derogatis (1983) were used (M = 0.31; SD = 0.31;
N = 974). Results suggest that the patient experienced clinically
significant decreases in general symptoms from start of treatment
(GSI= 1.36) to 1-year follow-up (GSI= 0.52), as her RCI= 2.80
exceeded the threshold (RCI = 1.96) for clinically significant
change. The GSI score at 1-year follow-up of 0.52, and post-
treatment of 0.37, was also below the cut off score (GSI = 0.58)
reported by Derogatis, indicating that the client still was in the
normal range at 1-year follow-up. The RCI for BDI was based
on the norms (M = 9.11, SD = 7.57) described by Beck et al.
(1996). The RCI = 3.10 between start of treatment (BDI = 24)
and 1-year follow-up (BDI = 9) were also above the threshold
(RCI = 1.96) for clinically significant change, and the BDI score
at 1-year follow-up of 9 was below the cut off score (BDI = 16),
calculated by the norms from Beck et al. (1996). When asked
about her subjective opinion of progress, Susan said that her life
had changed for the better, and that she was able to make choices
concerning further education and a new job.
CONCLUDING REMARKS
This case study illustrates that treatment resistant comorbid
anxiety patients can be treated with a generic MCT-model,
which further supports the transdiagnostic aspect of MCT
(Wells, 2009), which is in accordance with the hypothesis
outlined in the introduction. The case of Susan highlights that
multiple problems can be successfully treated simultaneously
by addressing common psychological processes like worry
and rumination. Thus, the results is in accordance with
research promoting the concept of transdiagnostic therapy,
and lends further evidence to the utility of a transdiagnostic
approach to psychopathology (Harvey et al., 2004; Moses
and Barlow, 2006; Wells, 2009). Applying disorder specific
models or originally derived CBT- models to the case
of Susan would have been a challenge, as she presented
multiple significant problems making it difficult to choose
the right disorder to focus on. Further, problems that are
subclinical and not properly addressed in a diagnosis-specific
treatment model could get more attention in a transdiagnostic
framework.
Worry, rumination, attentional biases, counterproductive
strategies and metacognitions can be relevant for conceptualizing
a highly comorbid patient. Susan learned to abandon her
old strategies for regulating emotions, through the explicit
focus on metacognitions, leading to a reduction in distress.
Systematic exposure is not an obligatory ingredient in MCT
and exposure therapy would have been challenging as Susan
had a variety of objects to confront. In the case of Susan,
treatment was directed to alter the style of thinking (CAS),
instead of challenging the validity of worry and negative thoughts,
which is standard procedure in CBT. The focus in therapy was
therefore exclusive on process instead of content of cognition.
Addressing the negative metacognitions about worry enabled
the patient to confront situations that she had earlier avoided,
because she knew that the worries were under her control. Wells
(2009) designates perceived lack of control over thinking as a
negative metacognition, and in the case of Susan, reduction
in the negative metacognitions of control seemed to be a key
mechanism of change. Frank (1971, p. 310) states “all successful
therapies implicitly or explicitly change the patients image of
himself from a person who is overwhelmed by his symptoms
and problems to one who can master them.” The concept of
being overwhelmed or out of control can be linked to the
concept of negative metacognitions regarding the perception of
lacking control over mental activity. The metacognitive model
gives clear guidance to how the negative metacognitions of
control could be changed using verbal attribution and behavioral
experiments.
Several limitations should be considered. First, an alternative
interpretation of the findings could be that the alliance with
the patient was the effective factor. An abundance of research
has shown that the alliance is a consistent predictor of outcome
(Wampold and Imel, 2015). However, few studies have examined
the within-person causal relationships between alliance, theory-
specific processes and outcome. In one such study, Hoffart et al.
(2012), found that initial patient-rated alliance predicted the
course of social anxiety throughout therapy and that this effect
was indirect through the cognitive process. Further, there was a
trend toward an indirect effect of weekly variations in alliance
rated by the individual therapist through weekly variations in
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subsequent cognitive process on weekly variations in subsequent
social anxiety. Thus, the results support a facilitative rather
than an active ingredient perspective on the role of alliance. In
any event, estimating the causal relationships between alliance,
CAS and outcome in Susan’s case would have required multiple
measurement of a considerable number over the course of
therapy (Fisher, 2015). This would have been a quite different
and much more resource-demanding study than the present
descriptive case study. However, this was one of the first
systematic evaluations of a patient treated with a generic
model of MCT, and she had previously received diagnose-
specific models without the same effect on comorbidity. Also
there was no previous report on problems in the therapeutic
alliance with the patient. Secondly, there is an imbalance in
the fact that the patient had been treated earlier with CBT-
protocols without specific effect, and then achieves a large effect
of the MCT-treatment in a relative short timespan. Since no
adherence measures were given for the previous CBT-treatment,
the lack of effect for previous CBT-treatments could be due to
poor conducted CBT. Third, the patient was not assessed for
personality disorder and the treatment was conducted in an
inpatient setting, which is not a typical format for delivering
of MCT.
Future research should address the efficacy of using a
generic MCT-approach contrasted with the best-documented
and widespread form of diagnosis-specific CBT.
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